ADVIA CENTAUR XP PROGESTERONE (PRGE) N/A 02382928

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-03-07 for ADVIA CENTAUR XP PROGESTERONE (PRGE) N/A 02382928 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[39784052] Siemens is filing the mdr conservatively as a result of the data included in the article. Siemens is unaware of the lots used to generate the published data. It is unknown the potential cross reactivity of supraphysiological concentrations of (b)(6) with the progesterone advia centaur assay. Siemens is investigating.
Patient Sequence No: 1, Text Type: N, H10


[39784053] Siemens was notified by the customer to an article publication in the journal of assisted reproduction and genetics suggesting interference from (b)(6) in the advia centaur progesterone assay causing falsely elevated progesterone results. There are no reports of adverse health consequences for falsely elevated advia centaur progesterone results and interference of (b)(6).
Patient Sequence No: 1, Text Type: D, B5


[64757022] Siemens filed the initial mdr 1219913-2016-00051 on 03/07/2016. The customer had notified siemens with regards to an article publication in the journal of assisted reproduction and genetics suggesting interference from dheas in the advia centaur progesterone assay causing falsely elevated progesterone results. On 12/29/2016 - additional information: siemens investigated cross-reactivity of dhea-s in the advia centaur xp progesterone assay, dimension vista loci progesterone assay, immulite/immulite 1000 progesterone assay and immulite 2000 progesterone assay and confirmed that dhea-s may cause elevated progesterone results in these assays. Dhea-s may be used as part of an ivf treatment plan for patients who are also being considered for fresh embryo transfer. A falsely elevated progesterone result around the clinical decision threshold of approximately 1. 0 ng/ml may lead to misinterpretation of progesterone levels and consideration of fresh embryo transfer cancellation and subsequent cryopreservation of the embryo(s). Siemens distributed urgent medical device correction cc 17-06. A. Us to customers in the united states and urgent field safety notice cc 17-06. A. Ous to customers outside the united states on january 4, 2017. These communications notify customers of the crossreactivity of dhea-s in the assays and advise customers to use an alternate method such as liquid chromatography- mass spectrometry (lc-ms) when measuring progesterone in patients using dhea-s supplements. No further investigation is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2016-00051
MDR Report Key5483561
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-03-07
Date of Report2017-01-10
Date of Event2016-02-10
Date Mfgr Received2016-12-29
Date Added to Maude2016-03-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. STEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Removal Correction Number1219913-01/04/2017-001-C
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP PROGESTERONE (PRGE)
Generic NamePROGESTERONE IMMUNOASSAY
Product CodeJLS
Date Received2016-03-07
Model NumberN/A
Catalog Number02382928
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.